GABRIEL BLOMQUIST: Open Payments
NPI 1659772176 · BILLINGS, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$418 in 7 payments from 6 companies in 2025. Trend: 2023 $178 · 2024 $4,353 · 2025 $418
Food & beverage: $418
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 1 | $125 |
| Insulet Corporation | 1 | $109 |
| Medtronic, Inc. | 1 | $88 |
| Novartis Pharmaceuticals Corporation | 2 | $45 |
| SANOFI-AVENTIS U.S. LLC | 1 | $27 |
| Lilly USA, LLC | 1 | $24 |
Products named: REZDIFFRA, Omnipod, MINIMED 780G, LEQVIO, TZIELD, MOUNJARO.
Industry payments across MT — which companies pay providers there.
